Your browser doesn't support javascript.
loading
Coronary Artery Calcium Score-Weighted Clinical Likelihood Model Performance in Patients with Stable Chest Pain and Coronary Artery Calcium Scores of Zero.
Tan, Yahang; Liu, Chang; Chen, Tao; Li, Yina; Wang, Chengjian; Zhao, Jia; Zhou, Jia.
Afiliación
  • Tan Y; Department of Cardiology, Beijing Chaoyang Hospital, Capital Medical University, 100069 Beijing, China.
  • Liu C; Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, 100069 Beijing, China.
  • Chen T; Clinical School of Thoracic, Tianjin Medical University, 300203 Tianjin, China.
  • Li Y; Department of Cardiology, Tianjin Chest Hospital, 300222 Tianjin, China.
  • Wang C; Department of Emergency, Hebei Petrochina Central Hospital, 065000 Langfang, Hebei, China.
  • Zhao J; Department of Cardiology, Tianjin Chest Hospital, 300222 Tianjin, China.
  • Zhou J; Department of Cardiology, Tianjin Chest Hospital, 300222 Tianjin, China.
Rev Cardiovasc Med ; 25(3): 85, 2024 Mar.
Article en En | MEDLINE | ID: mdl-39076944
ABSTRACT

Background:

For individuals with persistent stable chest pain (SCP) and a coronary artery calcium score (CACS) of 0, it might be challenging to establish the best risk assessment method for determining the individuals who will not benefit from further cardiovascular imaging testing (CIT). Thus, we investigated the CACS-weighted clinical likelihood (CACS-CL) model in SCP patients with a CACS of 0.

Methods:

Thus, to assess SCP, we originally enrolled 14,232 individuals for CACS and coronary computed tomography angiography (CCTA) scans between January 2016 and January 2018. Finally, patients with a CACS of 0 were included and followed up ​until January 2022. According to the established CACS-CL cutoffs of 15% and 5%, the associations between coronary artery disease (CAD) and major adverse cardiovascular events (MACEs) in risk groups were evaluated, alongside the net reclassification improvement (NRI).

Results:

Of the 6689 patients with a CACS of 0, the prevalence of CAD increased significantly (p < 0.0001) in patients with higher CACS-CL. However, there was no significant difference in the CAD distribution (p = 0.0637) between patients with CACS-CL < 5% and 5-15%. The association between the CACS-CL = 15%-determined risk groups and the occurrence of MACEs was stronger than for a CACS-CL = 5% (adjusted hazard ratio (HR) 7.24 (95% CI 1.93-16.42) versus 3.68 (95% CI 1.50-8.26)). Compared with the cutoff for CACS-CL = 5%, the NRI was 10.61% when using a cutoff for CACS-CL = 15%.

Conclusions:

Among patients with an SCP and CACS of 0, the CACS-CL model provided accurate predictions of CAD and MACEs. Compared to the cutoff for CACS-CL = 5%, the cutoff for CACS-CL = 15% seemed to be more effective and safer for deferring further CIT. Clinical Trial registration NCT04691037.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Rev Cardiovasc Med Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Rev Cardiovasc Med Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China